Literature DB >> 35397015

Electrochemical immuno determination of connective tissue growth factor levels on nitrogen-doped graphene.

Jing Ma1, Junhui Chen2, YuanYuan Li1, Xinru Zhang-Peng1, Hong Wei1, Wen Li1, Fangdi Hu3, Yan Zhang4.   

Abstract

Connective tissue growth factor (CTGF) is a disease marker of rheumatoid arthritis (RA), and its rapid and sensitive detection is essential for the diagnosis of RA. In this work, a three-dimensional pore structure of alkali-activated nitrogen-doped graphene (aN-G) was used as an electrode modification material, and a label-free electrochemical immunosensor for the sensitive detection of CTGF was successfully constructed by the formation of an amide bond between amino groups in protein and carboxyl groups on the carbon surface. Under optimized conditions, the sensor achieved accurate detection of CTGF in the wide range of 0.0625 ~ 2000 pg mL-1. It had good accuracy (95.0 ~ 100.1%), repeatability (1.2 ~ 2.2%), stability, selectivity, and a low limit of detection (0.0424 pg mL-1, S/N = 3). The sensor was used in serum samples of patients with RA, and CTGF was also successfully detected. Based on this, the electrochemical sensor is expected to become an effective method for RA diagnosis and treatment effect evaluation.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Alkali-activated nitrogen-doped graphene; Connective tissue growth factor; Disease classification; Electrochemical immunosensor; Rheumatoid arthritis

Mesh:

Substances:

Year:  2022        PMID: 35397015     DOI: 10.1007/s00604-022-05237-1

Source DB:  PubMed          Journal:  Mikrochim Acta        ISSN: 0026-3672            Impact factor:   5.833


  22 in total

Review 1.  The role of CTGF in diabetic retinopathy.

Authors:  Ingeborg Klaassen; Rob J van Geest; Esther J Kuiper; Cornelis J F van Noorden; Reinier O Schlingemann
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

2.  Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial.

Authors:  Luca Richeldi; Evans R Fernández Pérez; Ulrich Costabel; Carlo Albera; David J Lederer; Kevin R Flaherty; Neil Ettinger; Rafael Perez; Mary Beth Scholand; Jonathan Goldin; Kin-Hung Peony Yu; Thomas Neff; Seth Porter; Ming Zhong; Eduard Gorina; Elias Kouchakji; Ganesh Raghu
Journal:  Lancet Respir Med       Date:  2019-09-28       Impact factor: 30.700

3.  Diagnostic value of serum connective tissue growth factor in rheumatoid arthritis.

Authors:  Jiaqi Ren; Lin Sun; Xing Sun; Zhenzhen Ma; Xinyu Wang; Zhuo An; Jinxia Zhao
Journal:  Clin Rheumatol       Date:  2021-01-03       Impact factor: 2.980

Review 4.  Epilepsy biomarkers - Toward etiology and pathology specificity.

Authors:  Asla Pitkänen; Xavier Ekolle Ndode-Ekane; Niina Lapinlampi; Noora Puhakka
Journal:  Neurobiol Dis       Date:  2018-05-18       Impact factor: 5.996

5.  Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort.

Authors:  Kelly J Hunt; Miran A Jaffa; Sara M Garrett; Deirdre K Luttrell; Kenneth E Lipson; Maria F Lopes-Virella; Louis M Luttrell; Ayad A Jaffa
Journal:  Diabetes Care       Date:  2018-01-30       Impact factor: 19.112

6.  Effects of connective tissue growth factor (CTGF/CCN2) on condylar chondrocyte proliferation, migration, maturation, differentiation and signalling pathway.

Authors:  Xin Xing; Zhi Li; Zili Yu; Gu Cheng; Dianqi Li; Zubing Li
Journal:  Biochem Biophys Res Commun       Date:  2017-12-01       Impact factor: 3.575

7.  Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts.

Authors:  Se Hwan Mun; Jie Wan Kim; Seong Su Nah; Na Young Ko; Jun Ho Lee; Ju Dong Kim; Do Kyun Kim; Hyuk Soon Kim; Ji Da Choi; Soo Hyun Kim; Chang Keun Lee; Seung Hwa Park; Bo Kyung Kim; Hyung Sik Kim; Young Mi Kim; Wahn Soo Choi
Journal:  Arthritis Rheum       Date:  2009-03

8.  Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis.

Authors:  Xinyu Yang; Ke Lin; Shanmin Ni; Jianmin Wang; Qingqing Tian; Huaijun Chen; Matthew A Brown; Kaidi Zheng; Weitao Zhai; Li Sun; Shengwei Jin; Jianguang Wang
Journal:  Arthritis Res Ther       Date:  2017-11-22       Impact factor: 5.156

9.  Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves' orbital fibroblasts.

Authors:  Chieh-Chih Tsai; Shi-Bei Wu; Hui-Chuan Kau; Yau-Huei Wei
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

10.  Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.

Authors:  D M Bradham; A Igarashi; R L Potter; G R Grotendorst
Journal:  J Cell Biol       Date:  1991-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.